Free SO ORDERED - District Court of Delaware - Delaware


File Size: 44.3 kB
Pages: 4
Date: December 13, 2007
File Format: PDF
State: Delaware
Category: District Court of Delaware
Author: unknown
Word Count: 743 Words, 4,918 Characters
Page Size: 622 x 792 pts
URL

https://www.findforms.com/pdf_files/ded/37906/50.pdf

Download SO ORDERED - District Court of Delaware ( 44.3 kB)


Preview SO ORDERED - District Court of Delaware
Case 1:07-cv-00138-JJF Document 50 Filed 12/13/2007 Page1 of4
IN THE UNITED STATES DISTRICT COURT
. FOR THE DISTRICT OF DELAWARE
PFIZER INC., )
PFIZER PHARMACEUTICALS, LLC, )
PFIZER LIMITED, ) .
CP. PHARMACEUTICALS ) ,,,,, . pg
nstraarvxrtonai cv., ) tt tn? *
PFIZER IRELAND PHARMACEUTICAIIS,) { N ,
WARNER-LAMBERT COMPANY, ) E E A ( _, __ _ _Q
WARNER—LAI\/IBERT COMPANY, LLC ) · gg itil.? if Qéf Irillllilti
and > 1 . . ·
- I IJFT ‘’‘‘ e·»*-
WARNER LAMBERT EXPORT LTD. ) Lum
Plaintiffs, ) Q
)
v. ) Civil Action No. 07-138 (JIF)
i )
RANBAXY LABORATORIES )
LIMITED, and RANBAXY INC. )
)
Defendants. )
STIPULATED AMENDED ORDER OF FINAL JUDGMENT
WHEREAS, action having come before the Court upon consideration of
plaintiffs/counterclaim—defendants Ptizer Inc., Pfizer Pharmaceuticals, LLC, Ptizer
Limited, C.P. Pharmaceuticals International C.V., Ptizer Ireland Pharmaceuticals,
Warner-Lambert Company, Warner—Lambert Company, LLC and Wamer—Lambert
Export Limited’s (collectively “Pf1zer") Motion to Dismiss, and for Partial Judgment on
the Pleadings; and,
WHEREAS, a decision has been rendered (DI. 46, 47) and judgment entered on
November 29, 2007 (DI. 48) against Defendant’s Ranbaxy Laboratories, Limitediand. .
Ranbaxy Inc. (collectively "Ranbaxy") that United States Patent No. 4,681,893 (the
"’893 Patent") and its term extension are valid and enforceable and that Ranbaxy has

Case 1:07-cv-00138-JJF Document 50 Filed 12/13/2007 Page 2 of 4
i infringed the ‘893 patent; and,
WHEREAS, Pfizer has requested that this judgment be amended consistent with
35 U.S.C. § 271(e)(4); and,
WHEREAS, Ranbaxy has consented to the form of judgment as amended and
has reserved its rights to appeal consistent with the Federal Ru.les of Civil Procedure.
now, THEREFORE, IT IS ORDERED AND ADJUDGED, for the reasons
set forth in the Court’s Opinion and Order dated November 29, 2007, that Judgment shall
be entered in favor of plaintiffs Pfizer Inc, Pfizer Ireland Pharmaceuticals, Warner-
Lambert Company, Warner-Lambert Company LLC and Warner-Lambert Export, Ltd.
and against defendants Ranbaxy Laboratories Limited and Ranbaxy Inc. on Pfizer’s
claims that Ranbaxy has infringed United States Patent No. 4,681,893 (the "’893
Patent"); and it is further,
ORDERED AND ADJIJDGED that Judgment shall be entered in favor of Pfizer
and against Ranbaxy on all counterclaims alleging noninfringernent, invalidity, or
I unenforceability of the ’893 Patent or its patent term extension; and it is further,
ORDERED that pursuant to 35 U.S.C. § 271 (e) (4) (A), the eEective date of any
approval of Ranbaxy’s Abbreviated New Drug Application (as described in a letter dated
January 24, 2007 from Ranbaxy Inc. to Pfizer and attached to the Complaint as Exhibit
"D") shall be a date which is not earlier than the date of expiration of the ’893 Patent and
its patent term extension (September 24, 2009, wid:. attached six months of pediatric
I __ T __ exclusivity ending on March 24, 2010, to which Pfizer is entitled); and it is further,
ORDERED that pursuant to 35 U.S.C. § 2718 (e) (4) (B), defendants Ranbaxy I
Laboratories Limited and Ranbaxy Inc., each of their officers, agents, servants,
2

Case 1:07-cv-00138-JJF Document 50 Filed 12/13/2007 Page 3 of 4
_ employees and attorneys, and those persons in active concert or participation with them
or either of them me permanently enjoined from engaging in the manufacture, use, offer
to sell, or sale within the United States, or importation into the United States, of any
product comprising atorvastatin calcium and amlodipine besylate covered by, or the use
of which is covered by the ’893 Patent. I
CONNOLLY BOW/E LODGE & HUTZ LLP
/s/ Rudolf E. Hulz
Rudolf E. I-lutz (#484)
Email: [email protected]
J emey B. Bove (#998)
Mary W. Bourke (#2356)
The Nemours Building
1007 North Orange Street
P.O. Box 2207 ‘
‘ Wilmington, DE 19899-2207
(302) 658-9141
Attorneys for the Ploim‘@`s/Counta1·claim-
December dgfgndaygfs
Consented as to form:
RICHARDS LAYTON & FINGER, RA.
Of C0¤¤S9l /s/ Fr·ede·r·ic/c L. Cottrell, III
Joseph M. Reisman
William R. Ziiiimwman Fredeeele L. Cowell, III (#2555)
P4Y$0T1 L9M9lll9¤i Email: [email protected]
KNOBBE, MARTENS, OLSON Jameson A.L. Tweedie (#4927)
& BEAR, LLP Email: [email protected]
SITBCI, FIOOT Que Rodney Square
Irvine, CA 92614 _ gg Bgx 5;; e J _
(94% 760-0404 ‘ Wilmington, ns 19899 `
(302) 658-6541
DATED? DGCETDLBT ll, 2007 Attorwaysfor Defendants/Coumercloim-
plairzffs
3

Case 1:07-cv-00138-JJF Document 50 Filed 12/13/2007 Page 4 of 4
IT IS SO ORDERED this j 3 day cf December, 2007.
The it-Bgincrable Joseph I. Faman, Ir. " "
United States District Judge
5S0437_1.DOC
4